Clinical Trial Site
Daegu 42472
2 studies enrolling now · 3 studies all time
What they study most
Amyloidosis, Hereditary, Atypical Hemolytic-Uremic Syndrome, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Transthyretin Amyloidosis
Studies at this site
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
- Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
- HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis) — Completed